Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 12

1.

Resolvins and omega three polyunsaturated fatty acids: Clinical implications in inflammatory diseases and cancer.

Moro K, Nagahashi M, Ramanathan R, Takabe K, Wakai T.

World J Clin Cases. 2016 Jul 16;4(7):155-64. doi: 10.12998/wjcc.v4.i7.155. Review.

2.

Selected cytokines in patients with pancreatic cancer: a preliminary report.

Błogowski W, Deskur A, Budkowska M, Sałata D, Madej-Michniewicz A, Dąbkowski K, Dołęgowska B, Starzyńska T.

PLoS One. 2014 May 21;9(5):e97613. doi: 10.1371/journal.pone.0097613. eCollection 2014.

3.

Structural pathways of cytokines may illuminate their roles in regulation of cancer development and immunotherapy.

Guven-Maiorov E, Acuner-Ozbabacan SE, Keskin O, Gursoy A, Nussinov R.

Cancers (Basel). 2014 Mar 25;6(2):663-83. doi: 10.3390/cancers6020663.

4.

Extracellular DNA in pancreatic cancer promotes cell invasion and metastasis.

Wen F, Shen A, Choi A, Gerner EW, Shi J.

Cancer Res. 2013 Jul 15;73(14):4256-66. doi: 10.1158/0008-5472.CAN-12-3287. Epub 2013 May 30.

5.

Met receptor tyrosine kinase signaling induces secretion of the angiogenic chemokine interleukin-8/CXCL8 in pancreatic cancer.

Hill KS, Gaziova I, Harrigal L, Guerra YA, Qiu S, Sastry SK, Arumugam T, Logsdon CD, Elferink LA.

PLoS One. 2012;7(7):e40420. doi: 10.1371/journal.pone.0040420. Epub 2012 Jul 17.

6.

Interleukin-8, a promising predictor for prognosis of pancreatic cancer.

Chen Y, Shi M, Yu GZ, Qin XR, Jin G, Chen P, Zhu MH.

World J Gastroenterol. 2012 Mar 14;18(10):1123-9. doi: 10.3748/wjg.v18.i10.1123.

7.

Recent advances in underlying pathologies provide insight into interleukin-8 expression-mediated inflammation and angiogenesis.

Qazi BS, Tang K, Qazi A.

Int J Inflam. 2011;2011:908468. doi: 10.4061/2011/908468. Epub 2011 Dec 22.

8.

Up-regulation and sustained activation of Stat1 are essential for interferon-gamma (IFN-gamma)-induced dual oxidase 2 (Duox2) and dual oxidase A2 (DuoxA2) expression in human pancreatic cancer cell lines.

Wu Y, Antony S, Juhasz A, Lu J, Ge Y, Jiang G, Roy K, Doroshow JH.

J Biol Chem. 2011 Apr 8;286(14):12245-56. doi: 10.1074/jbc.M110.191031. Epub 2011 Feb 14.

9.

Examination of apoptosis signaling in pancreatic cancer by computational signal transduction analysis.

Rückert F, Dawelbait G, Winter C, Hartmann A, Denz A, Ammerpohl O, Schroeder M, Schackert HK, Sipos B, Klöppel G, Kalthoff H, Saeger HD, Pilarsky C, Grützmann R.

PLoS One. 2010 Aug 19;5(8):e12243. doi: 10.1371/journal.pone.0012243.

10.

CCL20/CCR6 expression profile in pancreatic cancer.

Rubie C, Frick VO, Ghadjar P, Wagner M, Grimm H, Vicinus B, Justinger C, Graeber S, Schilling MK.

J Transl Med. 2010 May 10;8:45. doi: 10.1186/1479-5876-8-45.

11.

Phenotype and genotype of pancreatic cancer cell lines.

Deer EL, González-Hernández J, Coursen JD, Shea JE, Ngatia J, Scaife CL, Firpo MA, Mulvihill SJ.

Pancreas. 2010 May;39(4):425-35. doi: 10.1097/MPA.0b013e3181c15963. Review.

12.

Interleukin-8 increases vascular endothelial growth factor and neuropilin expression and stimulates ERK activation in human pancreatic cancer.

Li M, Zhang Y, Feurino LW, Wang H, Fisher WE, Brunicardi FC, Chen C, Yao Q.

Cancer Sci. 2008 Apr;99(4):733-7. doi: 10.1111/j.1349-7006.2008.00740.x. Epub 2008 Feb 27.

Supplemental Content

Support Center